CIP 108541T
Mycobacteroides abscessus bolletii
CCUG 50184;DSM 45149;JCM 15297
CIP
Bacteria
yes
Mycobacterium abscessus bolletii
France
Marseille
01-01-2001
30 °C
Aerobic
Int. J. Syst. Evol. Microbiol, 2006, 56, 133, doi:10.1099/ijs.0.63969-0; Int. J. Syst. Evol. Microbiol, 2006, 56, 679, doi:10.1099/ijs.0.64295-0; Int. J. Syst. Evol. Microbiol, 2011, 61, 2311, doi:10.1099/ijs.0.023770-0; Int. J. Syst. Evol. Microbiol, 2011, 61, 2797, doi:10.1099/ijs.0.038521-0; J. Clin. Microbiol., 2011, 49(1), 62-68; J. Clin. Microbiol, 2011, 49(2), 491, pmid:21106786; J. Clin. Microbiol, 2011, 49(3), 1107, pmid:21177894; J. Bacteriol. , 2012, 194, 2756, doi:10.1128/JB.00354-12; Antimicrob. Agents Chemother, 2011, 55(2), 775, pmid:21135185; Int. J. Syst. Evol. Microbiol, 2016, 66, 4471, doi:10.1099/ijsem.0.001376; Front. Microbiol, 2018, 9, 67, doi:10.3389/fmicb.2018.00067; Int. J. Syst. Evol. Microbiol, 2018, 68, 1411, doi:10.1099/ijsem.0.002711
2
2004, M. Drancourt, Timone Hosp., Marseille, France: strain BD
Broncho-alveolar liquid
Risk group: 2 (classification according to CIP)
B
Processing
processing in progress, please wait...